News

AddToAny

Google+ Facebook Twitter Twitter

Fractional COVID-19 booster vaccines

Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full-dose with fewer side effects, according to a new study.

The researchers found that a half dose of a Pfizer COVID-19 booster vaccine elicited a non-inferior immune response to a full dose in Mongolian adults who previously had AstraZeneca or Sinopharm COVID-19 shots.

But it found half-dose boosting may be less effective in adults primed with the Sputnik V COVID-19 vaccine.

The research is part of an international clinical trial, which also includes Australia and Indonesia, that’s investigating the different COVID-19 booster shot approaches to help guide future vaccination strategies.

The first batch of findings, involving 601 participants over 18 years old from Mongolia, reports on the initial responses seen 28 days after vaccination. The study is the first of its kind to assess and compare COVID-19 vaccines widely used in low- and middle-income countries.

MCRI Professor Kim Mulholland, who also sits on the WHO SAGE committee, said: “Fractional dosing may improve COVID-19 booster acceptability and uptake and reduce the per-dose cost of COVID-19 booster programmes.”

The study found half-dose boosted participants reported fewer local reactions than those receiving full doses (60% versus 72%) including less pain and tenderness. They also reported fewer systemic reactions (25% versus 32%).

bit.ly/3T63V0f

Image credit | Getty

Related Articles

white cells attacking cancer - CREDIT- Science Photo Library f0234989.jpg

Taming the chaotic protein that fuels cancers

MYC is a protein that it is claimed is responsible for making the majority of human cancer cases worse.

Tissue grafts that escape immune system rejection

In a preclinical breakthrough, researchers have developed a technology that may one day eliminate the need for immunosuppressive drugs in transplant patients.

How to measure improvement in long COVID

Researchers have reached an agreement on how to measure the severity and impact of long COVID by identifying a “Core Outcome Measure Set” (COMS).

Benefits of exercise and the immune system

A new study may offer molecular insights into the connection between exercise and inflammation.

Top